Cantitate/Preț
Produs

Dose Optimization in Drug Development: Drugs and the Pharmaceutical Sciences

Editat de Rajesh Krishna
en Limba Engleză Hardback – mai 2006
This reference provides a concise overview of the key principles in dose selection and optimization and demonstrates applicability to recent successful new drug applications. Compiling key issues and current research on safety, efficacy, and clinical pharmacology, and PK-PD, this volume critically highlights the multidisciplinary nature of drug development and spans the fields of pharmacokinetics, clinical pharmacology, biostatistics, and experimental medicine.
Citește tot Restrânge

Din seria Drugs and the Pharmaceutical Sciences

Preț: 130392 lei

Preț vechi: 159015 lei
-18% Nou

Puncte Express: 1956

Preț estimativ în valută:
24962 25947$ 20696£

Carte tipărită la comandă

Livrare economică 06-20 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781574448085
ISBN-10: 1574448080
Pagini: 320
Ilustrații: 68 b/w images, 58 color images, 19 tables and 4 halftones
Dimensiuni: 152 x 229 x 22 mm
Greutate: 0.57 kg
Ediția:1
Editura: CRC Press
Colecția CRC Press
Seria Drugs and the Pharmaceutical Sciences

Locul publicării:Boca Raton, United States

Public țintă

Academic, Professional, and Professional Practice & Development

Cuprins

Introduction to Dose Optimization in Drug Development. Bridging Preclinical and Clinical Development: Disease Progression Modeling in Translational Research. Bridging Preclinical and Clinical Development: Biomarker Validation and Qualification. Dose Selection for First-In-Human Study: A Regulatory Perspective. Novel Clinical Trial Designs in Clinical Pharmacology and Experimental Medicine. Biomarkers, Surrogate Endpoints, and Clinical Endpoints in the Development of Cardiovascular Drugs: A Regulatory Perspective. Pharmacokinetic and Pharmacodynamic Variability. Pharmacogenetics and Dose Response: Dose Individualization. Optimal Dose Finding in Drug Development: Approaches and Regulatory Perspectives. Optimal Dose Selection in Drug Development: Role of Population Pharmacokinetics in Phase 3. Dose Optimization Strategy for Strattera, A CYP2D6 Substrate. Pediatric Dose Optimization Using Pharmacokinetics/Pharmacodynamics


Descriere

This reference provides a concise overview of the key principles in dose selection and optimization and demonstrates applicability to recent successful new drug applications. Compiling key issues and current research on safety, efficacy, and clinical pharmacology, and PK-PD, this volume critically highlights the multidisciplinary nature of drug development and spans the fields of pharmacokinetics, clinical pharmacology, biostatistics, and experimental medicine.